Eli Lilly Eyeing More R&D Pacts in India (India)
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly plans to increase its research and development (R&D) outsourcing in India this year and sign a few more agreements with Indian pharmaceutical companies as a way to cut drug development costs. Eli Lilly signed contracting deals with Mumbai-based Nicholas Piramal in January this year and Hyderabad-based Suven Life Sciences in August 2006. Eli Lilly India managing director Sandeep Gupta says any outsourcing decisions are being made at Eli Lilly's global headquarters. (Click here for more